Lysosomal dysfunction is a common feature of aging-associated neurodegenerative diseases, including Alzheimer’s disease (AD), which is characterized by the accumulation of toxic beta-amyloid (Aβ) and tau protein aggregates in the brain [1]. This evidence concerns the gene MAPT and Alzheimer disease.